醫療季淨利分析

最後更新 2025-09-10 08:39:55 (UTC+8)

季淨利趨勢分析

醫療類股公司整體季淨利成長趨勢。

醫療類股調整後季淨利與 XLV ETF走勢圖

FindBillion.com

季節調整後季淨利成長率


季淨利季增率	-5%
季淨利年增率	37.6%

季淨利與股價相關性分析

判斷醫療類股ETF(XLV) 股價和醫療類股整體季節調整後季淨利有無相關性，若中高度相關性，可由整體季節調整後季淨利推估股價是否合理。

醫療類股整體季節調整後季淨利-股價散佈圖

醫療類股整體季節調整後季淨利與股價低度相關，相關性越高，參考意義越大。

醫療類股整體季節調整後季淨利與股價間的
決定係數

低度相關 0.18

FindBillion.com

📢

Loading Ad...

相關個股

醫療相關的個股，以及該個股的季淨利季增率、年增率。

代碼	公司名稱	季淨利季增率	季淨利年增率
HOLX	Hologic, Inc.	轉虧為盈	0.2%
IONS	Ionis Pharmaceuticals, Inc.	轉虧為盈	轉虧為盈
MASI	Masimo Corporation	轉虧為盈	220.6%
VRNA	Verona Pharma plc	轉虧為盈	轉虧為盈
TAK	Takeda Pharmaceutical Company Limited	轉虧為盈	30.4%
ONC	BeOne Medicines Ltd.	9802.4%	轉虧為盈
NBIX	Neurocrine Biosciences, Inc.	894.9%	65.4%
BIO	Bio-Rad Laboratories, Inc.	825.9%	轉虧為盈
ARGX	argenx SE	623.9%	轉虧為盈
GMAB	Genmab A/S	410.5%	51.2%
ILMN	Illumina, Inc.	301.5%	轉虧為盈
VRTX	Vertex Pharmaceuticals Incorporated	286.2%	轉虧為盈
TEVA	Teva Pharmaceutical Industries Limited	238.2%	轉虧為盈
LLY	Eli Lilly and Company	139.1%	90.8%
SNY	Sanofi	137.4%	254%
GMED	Globus Medical, Inc.	131.7%	538.7%
HALO	Halozyme Therapeutics, Inc.	112.3%	77.1%
BSX	Boston Scientific Corporation	104.3%	144.8%
BIIB	Biogen Inc.	103%	8.8%
CRL	Charles River Laboratories International, Inc.	90.7%	-41.9%
BMRN	BioMarin Pharmaceutical Inc.	75%	124.4%
RGEN	Repligen Corporation	74.6%	347.6%
ALGN	Align Technology, Inc.	73.7%	29%
SNN	Smith & Nephew plc	65.3%	71.9%
IQV	IQVIA Holdings Inc.	58.2%	-26.7%
HQY	HealthEquity, Inc.	49.6%	67.1%
A	Agilent Technologies, Inc.	49.3%	19.1%
GRFS	Grifols, S.A.	43.3%	688.8%
RVTY	Revvity, Inc.	40.2%	-30.2%
ICLR	ICON Public Limited Company	40.2%	24.5%
ATR	AptarGroup, Inc.	37.6%	23.5%
SYK	Stryker Corporation	37.4%	7.2%
CORT	Corcept Therapeutics Incorporated	36.7%	-1%
REGN	Regeneron Pharmaceuticals, Inc.	36.1%	-2.8%
WST	West Pharmaceutical Services, Inc.	35%	18.4%
AZN	AstraZeneca PLC	34%	27.1%
COR	Cencora, Inc.	32.9%	42.2%
BDX	Becton, Dickinson and Company	30.2%	17.9%
ABT	Abbott Laboratories	29.3%	36.6%
MDT	Medtronic plc	28.8%	-0.2%
PFE	Pfizer Inc.	28.3%	11920.8%
STE	STERIS plc	25.9%	22%
GILD	Gilead Sciences, Inc.	25.2%	21.4%
DOCS	Doximity, Inc.	19.7%	28.9%
GSK	GSK plc	18.9%	23%
ABBV	AbbVie Inc.	18.5%	-31.1%
DVA	DaVita Inc.	17.9%	-10.5%
ZTS	Zoetis Inc.	15.1%	15.1%
IDXX	IDEXX Laboratories, Inc.	15%	44.6%
QGEN	Qiagen N.V.	14.5%	轉虧為盈
PEN	Penumbra, Inc.	12.6%	轉虧為盈
FMS	Fresenius Medical Care AG & Co. KGaA	11%	20.5%
HCA	HCA Healthcare, Inc.	10.7%	13.1%
LH	Labcorp Holdings Inc.	9.8%	15.9%
ZBH	Zimmer Biomet Holdings, Inc.	7.9%	-37.1%
STVN	Stevanato Group S.p.A.	7.9%	44%
EW	Edwards Lifesciences Corporation	7.7%	-9.3%
MOH	Molina Healthcare, Inc.	6.9%	-15.3%
MTD	Mettler-Toledo International Inc.	6.3%	-8.8%
EHC	Encompass Health Corporation	5.1%	24.5%
DGX	Quest Diagnostics Incorporated	3.7%	22.7%
INCY	Incyte Corporation	3.5%	轉虧為盈
ISRG	Intuitive Surgical, Inc.	2.3%	25%
UHS	Universal Health Services, Inc.	1.3%	22.2%
TMO	Thermo Fisher Scientific Inc.	0.2%	4.5%
NVO	Novo Nordisk A/S	0.2%	32.2%
ENSG	The Ensign Group, Inc.	-3.5%	18.9%
WAT	Waters Corporation	-4.9%	3.1%
RMD	ResMed Inc.	-5.6%	29.9%
MRK	Merck & Co., Inc.	-6.1%	-18.8%
VEEV	Veeva Systems Inc.	-6.9%	17.1%
UTHR	United Therapeutics Corporation	-7.3%	11.3%
AMGN	Amgen Inc.	-8.4%	92%
THC	Tenet Healthcare Corporation	-8.8%	11.2%
COO	The Cooper Companies, Inc.	-12.4%	-6.1%
MEDP	Medpace Holdings, Inc.	-13.9%	2.2%
SOLV	Solventum Corporation	-14%	1.1%
HSIC	Henry Schein, Inc.	-14.1%	-17.3%
BAX	Baxter International Inc.	-16.2%	轉虧為盈
HLN	Haleon plc	-17.8%	轉虧為盈
ELV	Elevance Health Inc.	-18%	-24.2%
CHE	Chemed Corporation	-19.4%	-25.9%
RDY	Dr. Reddy's Laboratories Limited	-24.5%	1.9%
EXEL	Exelixis, Inc.	-25.2%	-18.3%
GEHC	GE HealthCare Technologies Inc.	-25.4%	13.6%
PHG	Koninklijke Philips N.V.	-27.2%	-46.8%
MCK	McKesson Corporation	-31.4%	-14.3%
DXCM	DexCom, Inc.	-32.4%	25.3%
ALC	Alcon Inc.	-34.4%	-21.1%
BMY	Bristol-Myers Squibb Company	-37%	-22%
CAH	Cardinal Health, Inc.	-39.5%	1.3%
ELAN	Elanco Animal Health Incorporated	-39.8%	轉虧為盈
PODD	Insulet Corporation	-40%	-88.1%
DHR	Danaher Corporation	-46.9%	-38.8%
CVS	CVS Health Corporation	-48.4%	-42.3%
JNJ	Johnson & Johnson	-53.8%	18.2%
HUM	Humana Inc.	-53.9%	-19.7%
UNH	UnitedHealth Group Incorporated	-53.9%	-19.2%
RPRX	Royalty Pharma plc	-95.1%	-70.4%
NVS	Novartis AG	-99.9%	-99.9%
TECH	Bio-Techne Corporation	-100%	-100%
CNC	Centene Corporation	-100%	-100%
MDGL	Madrigal Pharmaceuticals, Inc.	-	-
ASND	Ascendis Pharma A/S	-	-
JAZZ	Jazz Pharmaceuticals plc	-	-100%
INSM	Insmed Incorporated	-	-
ALNY	Alnylam Pharmaceuticals, Inc.	-	-
VTRS	Viatris Inc.	-	-
WBA	Walgreens Boots Alliance, Inc.	-	-100%
EXAS	Exact Sciences Corporation	-	-
ABVX	Abivax S.A.	-	-
TEM	Tempus AI, Inc.	-	-
AXSM	Axsome Therapeutics, Inc.	-	-
BBIO	BridgeBio Pharma, Inc.	-	-
CYTK	Cytokinetics, Incorporated	-	-
BNTX	BioNTech SE	-	-
SMMT	Summit Therapeutics Inc.	-	-
RYTM	Rhythm Pharmaceuticals, Inc.	-	-
RVMD	Revolution Medicines, Inc.	-	-
ROIV	Roivant Sciences Ltd.	-	-100%
RNA	Avidity Biosciences, Inc.	-	-
MRNA	Moderna, Inc.	-	-
CAI	Caris Life Sciences, Inc.	-	-100%
RGC	Regencell Bioscience Holdings Limited	-	-
NTRA	Natera, Inc.	-	-
GH	Guardant Health, Inc.	-	-

警語

1. 資料僅供參考，不做任何獲利保證及特定股票與點位推薦建議。

2. 資料並不完整，需要完整資料請至相關網站索取。

3. 任何股市數據分析皆存在倖存者偏差。

醫療類股